Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Using polymerase chain reaction and direct sequencing, we analyzed the EXT1 and EXT2 genes in three familial cases and one sporadic case of HME in Taiwanese patients.
|
16638657 |
2006 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
To identify possible mutations in our previously cloned candidate gene for hereditary multiple exostoses type II (EXT2) in affected members of EXT families so as to confirm that it is the disease-causing gene.
|
11593646 |
1999 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses.
|
9463333 |
1998 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
In patients suspected to be affected by MO, we recommend a quantitative analysis such as MLPA, followed by direct sequence analysis for the screening of the EXT1 and EXT2 genes.
|
15586175 |
2005 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
To further evaluate the relevance of LDL-receptor (LDLr) pathway and heparan sulfate proteoglycans (HSPGs) in TG homeostasis, we analyzed fasting and postprandial TG levels in mice bearing combined heterozygous mutations in both Exostosin (Ext) 1 and Ldlr, in subjects with hereditary multiple exostosis (HME) due to a heterozygous loss-of-function mutation in EXT1 or EXT2 (N = 13), and in patients with heterozygous mutations in LDLR [familial hypercholesterolemia (FH)] and SNPs in major HSPG-related genes (n = 22).
|
25568062 |
2015 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The exostosin-1 (EXT-1) and exostosin-2 (EXT-2) gene mutations are well-defined molecular mechanisms in the pathogenesis of HME.
|
31211456 |
2019 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Hereditary multiple exostoses (HME), an autosomal skeletal disorder characterized by cartilage-capped excrescences, has been ascribed to mutations in EXT 1 and EXT 2, two tumor suppressor-related genes encoding glycosyltransferases involved in the heparan sulfate proteoglycan (HSPG) biosynthesis.
|
10934647 |
2000 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Identification of four novel EXT1 and EXT2 mutations in five Chinese pedigrees with hereditary multiple exostoses.
|
19839753 |
2009 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
There are no data about EXT1 and EXT2 pathogenic variants in patients with multiple osteochondromas in Brazilian population.
|
29529714 |
2018 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The disease we discuss here is hereditary multiple exostoses (HME), a disorder caused by mutations in HS synthesizing enzymes EXT1 and EXT2, leading to HS deficiency.
|
23821404 |
2013 |
Hereditary Multiple Exostoses
|
0.700 |
Biomarker
|
disease |
BEFREE |
EXT1 located on chromosome 8q23-q24 and EXT2 located on 11p11-p12 are the main disease-causing genes which are responsible for ~90% of HME cases.
|
24297320 |
2014 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Linkage analysis aimed to discern one of the known EXT genes demonstrated linkage of the HME phenotype to the EXT2 gene.
|
14654969 |
2004 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Additionally, we identified 22 novel EXT1 and EXT2 mutations in this Japanese MO cohort.
|
26961984 |
2016 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Hereditary multiple exostoses (HME, OMIM 133700, 133701) results from mutations in EXT1 and EXT2, genes encoding the copolymerase responsible for heparan sulfate (HS) biosynthesis.
|
12417417 |
2002 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
While factors for severity remain unknown, mutations in exostosin 1 and exostosin 2 genes, encoding glycosyltransferases involved in the biosynthesis of ubiquitously expressed heparan sulphate (HS) chains, are associated with MHE.
|
23771188 |
2013 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A heterozygous transition (c.743+1G>A) in the EXT2 gene, which co-segregated with the HME phenotype in this family, was identified.
|
24728384 |
2014 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Screening and identifying the gene mutation of EXT1, EXT2 and EXT3 associated with multiple exostosis (ME) and the expression in tumor tissues.
|
30262140 |
2018 |
Hereditary Multiple Exostoses
|
0.700 |
Biomarker
|
disease |
BEFREE |
EXT2 has an open reading frame encoding 718 amino acids with an overall homology of 30.9% with EXT1, suggesting that a family of related genes might be responsible for the development of EXT.
|
8894688 |
1996 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
In this study, we have characterized exostosis chondrocytes from three patients with HME (one with EXT1 and two with EXT2 germline mutations) and from one individual with a non-HME, isolated exostosis.
|
10750558 |
2000 |
Hereditary Multiple Exostoses
|
0.700 |
Biomarker
|
disease |
BEFREE |
Using 2-point linkage analysis the EXT phenotype was shown to be linked to the recently cloned EXT2 gene on chromosome 11p11.
|
10671060 |
1998 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
New mutations of EXT1 and EXT2 genes in German patients with Multiple Osteochondromas.
|
19344451 |
2009 |
Hereditary Multiple Exostoses
|
0.700 |
Biomarker
|
disease |
BEFREE |
In this study we investigated 33 unrelated Polish probands with the clinical and radiological diagnosis of HME by means of Sanger sequencing and MLPA for all coding exons of EXT1 and EXT2.
|
24532482 |
2014 |
Hereditary Multiple Exostoses
|
0.700 |
Biomarker
|
disease |
BEFREE |
Mutations in Exostosin-1 (EXT1) or Exostosin-2 (EXT2) cause the autosomal dominant disorder multiple osteochondromas (MO).
|
22037484 |
2012 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
EXT1 and EXT2 are the two genes known to harbor heterozygous loss-of-function mutations that account for the vast majority of the primary genetic component of HME.
|
25498973 |
2015 |
Hereditary Multiple Exostoses
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A novel mutation in the EXT2 gene identified in two unrelated Chinese families with hereditary multiple exostoses.
|
18294062 |
2007 |